Skip to main content
SpringerLink
Log in

Journals’ TOP guidelines transparency level should be disclosed

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Center for Open Science. TOP Guidelines. https://cos.io/our-services/top-guidelines/

  2. Nosek BA, Alter G, Bank, GC et al (2015) Scientific standards. Promoting an open research culture. Science 348:1422–1425

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jansen of Lorkeers SJ, Doevendans PA, Chamuleau SA (2014) All preclinical trials should be registered in advance in an online registry. Eur J Clin Investig 44:891–892

    Article  Google Scholar 

  4. Dal-Re R, Ioannidis JP, Bracken MB et al. (2014) Making prospective registration of observational research a reality. Sci Transl Med 6, 224cm1

  5. National Institutes of Health. NIH policy on the dissemination of NIH-funded clinical trial information. NOT-OD-16-149. September 16, 2016. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-149.html

Download references

Author information

Authors and Affiliations

  1. Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain

    Rafael Dal-Ré

  2. Unidad de Epidemiología, Instituto de Investigación Sanitaria-Hospital Universitario Fundación Jiménez Díaz, Universidadad Autónoma de Madrid, Avda. Reyes Católicos 2, E-28040, Madrid, Spain

    Rafael Dal-Ré

Authors
  1. Rafael Dal-Ré
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rafael Dal-Ré.

Ethics declarations

Competing interests

The author declares that he has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dal-Ré, R. Journals’ TOP guidelines transparency level should be disclosed. Eur J Clin Pharmacol 74, 249–250 (2018). https://doi.org/10.1007/s00228-017-2370-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-017-2370-8

Search

Navigation